1. Home
  2. EZGO vs PRFX Comparison

EZGO vs PRFX Comparison

Compare EZGO & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EZGO Technologies Ltd.

EZGO

EZGO Technologies Ltd.

HOLD

Current Price

$1.01

Market Cap

2.4M

ML Signal

HOLD

Logo PainReform Ltd.

PRFX

PainReform Ltd.

HOLD

Current Price

$1.00

Market Cap

2.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZGO
PRFX
Founded
2014
2007
Country
China
Israel
Employees
N/A
N/A
Industry
Motor Vehicles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.6M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
EZGO
PRFX
Price
$1.01
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
77.8K
193.8K
Earning Date
07-01-2025
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.58
52 Week High
$3.30
$5.39

Technical Indicators

Market Signals
Indicator
EZGO
PRFX
Relative Strength Index (RSI) 45.59 42.77
Support Level $0.88 $0.97
Resistance Level $1.33 $1.23
Average True Range (ATR) 0.12 0.09
MACD 0.01 0.01
Stochastic Oscillator 29.24 29.06

Price Performance

Historical Comparison
EZGO
PRFX

About EZGO EZGO Technologies Ltd.

EZGO Technologies Ltd is engaged in the sale of e-bicycles and battery and e-bicycle rentals, complemented by the sale of battery packs, battery cell trading and charging pile business. Its product categories include e-bicycle, Intelligent unmanned patrol car, e-motorcycle and e-moped and urban style e-tricycle. Its segments include the Battery cells and packs, electronic control system and intelligent robot segment. and the E-bicycle sales segment. The company generates maximum revenue from the Battery cells and packs segment.

About PRFX PainReform Ltd.

PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.

Share on Social Networks: